Tivic Health Systems (TIVC) Set to Announce Quarterly Earnings on Tuesday

Tivic Health Systems (NASDAQ:TIVCGet Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, November 14th. Analysts expect the company to announce earnings of ($7.00) per share for the quarter.

Tivic Health Systems (NASDAQ:TIVCGet Free Report) last released its quarterly earnings results on Monday, August 14th. The company reported ($7.00) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($8.00) by $1.00. Tivic Health Systems had a negative net margin of 638.47% and a negative return on equity of 204.39%. The company had revenue of $0.16 million during the quarter, compared to analysts’ expectations of $0.63 million. On average, analysts expect Tivic Health Systems to post $-33 EPS for the current fiscal year and $-24 EPS for the next fiscal year.

Tivic Health Systems Stock Up 0.8 %

Shares of NASDAQ:TIVC opened at $1.19 on Friday. Tivic Health Systems has a twelve month low of $1.15 and a twelve month high of $174.00. The company has a market cap of $1.75 million, a price-to-earnings ratio of -0.02 and a beta of 2.08. The business has a 50 day moving average price of $1.78 and a 200 day moving average price of $6.40.

Institutional Investors Weigh In On Tivic Health Systems

An institutional investor recently bought a new position in Tivic Health Systems stock. Renaissance Technologies LLC purchased a new stake in Tivic Health Systems, Inc. (NASDAQ:TIVCFree Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 122,234 shares of the company’s stock, valued at approximately $197,000. Renaissance Technologies LLC owned 1.27% of Tivic Health Systems at the end of the most recent reporting period. Hedge funds and other institutional investors own 9.62% of the company’s stock.

Tivic Health Systems Company Profile

(Get Free Report)

Tivic Health Systems Inc operates as a health technology company, focuses on developing and commercializing non-invasive bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal congestion pains. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S.

Featured Stories

Earnings History for Tivic Health Systems (NASDAQ:TIVC)

Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.